We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$8.86B
AUM Growth
-$2.55B
Cap. Flow
-$5.06B
Cap. Flow %
-57.1%
Top 10 Hldgs %
43.45%
Holding
1,963
New
890
Increased
225
Reduced
270
Closed
453

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 8.59%
2 Industrials 6.75%
3 Technology 6.53%
4 Communication Services 5.94%
5 Financials 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTPA.WS
1401
DELISTED
Highland Transcend Partners I Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HTPA.WS
$23K ﹤0.01%
+18,307
New +$31.3K
SDACW
1402
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$22K ﹤0.01%
+31,237
New +$21.5K
TBLTW
1403
DELISTED
ToughBuilt Industries, Inc. Warrant
TBLTW
$21K ﹤0.01%
104,000
SHIPZ
1404
DELISTED
Seanergy Maritime Holdings Corp Class B Warrant
SHIPZ
$21K ﹤0.01%
178,500
HGASW
1405
DELISTED
Global Gas Corporation Warrant
HGASW
$19K ﹤0.01%
+30,907
New +$30.6K
CELUW
1406
DELISTED
Celularity Inc
CELUW
$17K ﹤0.01%
15,000
ARTLW
1407
DELISTED
Artelo Biosciences, Inc. Warrant
ARTLW
$15K ﹤0.01%
35,000
THCAW
1408
DELISTED
Tuscan Holdings Corp. II Warrant
THCAW
$14K ﹤0.01%
17,500
OTRAW
1409
DELISTED
OTR Acquisition Corp. Warrant
OTRAW
$11K ﹤0.01%
+17,500
New +$18.9K
OGEN icon
1410
Oragenics
OGEN
$2.26M
$9K ﹤0.01%
6
SVOKW
1411
DELISTED
Seven Oaks Acquisition Corp. Warrant
SVOKW
$9K ﹤0.01%
+10,000
New +$13.6K
ABBV icon
1412
CALL
AbbVie
ABBV
$443B
-259,200
Closed -$27.8M
ABBV icon
1413
PUT
AbbVie
ABBV
$443B
-581,400
Closed -$62.3M
ABLLW
1414
DELISTED
Abacus Life Warrant
ABLLW
-57,843
Closed -$66K
ABM icon
1415
ABM Industries
ABM
$2.81B
-6,948
Closed -$263K
ACB
1416
Aurora Cannabis
ACB
$173M
-1,211
Closed -$101K
ACIU icon
1417
AC Immune
ACIU
$223M
-191,162
Closed -$988K
ACIW icon
1418
ACI Worldwide
ACIW
$5.83B
-47,552
Closed -$1.83M
ACMR icon
1419
ACM Research
ACMR
$5.42B
-37,728
Closed -$1.02M
ACM icon
1420
CALL
Aecom
ACM
$9.3B
-177,500
Closed -$8.84M
ACM icon
1421
PUT
Aecom
ACM
$9.3B
-15,000
Closed -$747K
ACRS icon
1422
Aclaris Therapeutics
ACRS
$726M
-98,845
Closed -$640K
ADBE icon
1423
Adobe
ADBE
$99.5B
-1,199
Closed -$600K
AFL icon
1424
Aflac
AFL
$64.9B
-10,090
Closed -$449K
AG icon
1425
First Majestic Silver
AG
$7.41B
-180,735
Closed -$2.43M

Similar funds

Verition Fund Management's Q1 2021 Portfolio in Review

As of Q1 2021, Verition Fund Management held 1,963 positions worth $8.86B, down 22% from $11.4B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Verition Fund Management withdrew a net $5.06B in Q1 2021, closing 453 positions and reducing 270 holdings. Its most notable exit was Netflix, an estimated $314M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 8.6% of assets, up from 7.4% a quarter earlier, followed by Industrials and Technology.

Against the trend, Verition Fund Management opened a new position in State Street SPDR Portfolio Intermediate Term Corporate Bond ETF worth $30.7M.

  • Verition Fund Management's largest Q1 2021 buy was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF: 846,660 shares worth $30.7M.
  • Verition Fund Management added most to Costco in Q1 2021, an estimated $86.9M increase.
  • Verition Fund Management's biggest Q1 2021 reduction was GFL Environmental Inc. Tangible Equity Units, cutting an estimated $1.21B.
  • Verition Fund Management fully exited Netflix in Q1 2021, selling an estimated $314M.
  • Verition Fund Management's ten largest holdings make up 43% of its $8.86B portfolio in Q1 2021.
  • Verition Fund Management opened 890 new positions and closed 453 in Q1 2021.
  • Verition Fund Management's portfolio value fell 22% quarter-over-quarter to $8.86B.

Based on Verition Fund Management's 13F filing for Q1 2021, filed 18 May 2021.